SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director at Guardant Health made a very small, pre-planned sale of common stock valued at approximately $7,800.
• Market Impact: Negligible, as the transaction size is immaterial relative to the company's market capitalization and was executed under a 10b5-1 plan.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	SERVICES-MEDICAL LABORATORIES

Insider Information

Field	Value
Name	Tariq Musa
CIK	0001968281
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-17
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	116
Price Per Share	$66.95
Total Value	$7,766.20
Shares Owned After	7,725
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$7,766.20
% of Market Cap	<0.001%
Shares Transacted	116
% of Shares Outstanding	<0.001%
Post-Transaction Ownership	7,725 shares (<0.01% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The ~$7.8k sale is insignificant for a company with an $8.16 billion market cap.
• Ownership Concentration: The director's post-transaction ownership of 7,725 shares represents a negligible fraction (<0.01%) of the 124.7 million total shares outstanding.
• Transaction Significance: The sale represents less than 0.001% of both market cap and shares outstanding, classifying it as a low-significance event. The sale constituted only ~1.5% of the insider's direct holdings, indicating it was not a major liquidation of their position.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is too small to influence market perception. The fact that it was conducted under a 10b5-1 trading plan further reduces its informational value, as it was pre-scheduled and not a reaction to current events.

Volume & Sentiment

• Expected Volume Impact: No discernible impact on trading volume is expected.
• Sentiment Indicator: Neutral. This type of small, planned sale is common for insiders for personal financial management and does not signal a change in outlook for the company.

Investment Insights

Positive Market Indicators

• None from this filing.

Risk Factors

• None from this filing.

Key Takeaways

1. The transaction is a routine, non-discretionary sale by a director.
2. The sale value is immaterial to both the company's valuation and the insider's overall position.
3. The use of a 10b5-1 plan indicates the sale was pre-arranged and not based on immediate, non-public information.

Additional Context

Transaction Notes

• Special Circumstances: The filing indicates the transaction was made pursuant to a Rule 10b5-1 trading plan, which allows insiders to set up a pre-arranged plan to buy or sell company stock.